Viking Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 11/13/2024 | 16.62 M | $1.05 B | 0.48% | 14.98% |
VANGUARD GROUP INC | 11/13/2024 | 10.17 M | $643.71 M | 0.70% | 9.17% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.38 M | $340.63 M | 100.00% | 4.85% |
STATE STREET CORP | 11/14/2024 | 4.67 M | $295.92 M | -8.75% | 4.21% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 2.22 M | $140.78 M | 3.98% | 2.00% |
JPMORGAN CHASE & CO | 11/08/2024 | 2.12 M | $133.99 M | -6.01% | 1.91% |
MORGAN STANLEY | 11/14/2024 | 1.87 M | $118.70 M | 97.93% | 1.69% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.86 M | $118.02 M | 0.25% | 1.68% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.70 M | $107.63 M | 135.66% | 1.53% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.47 M | $93.24 M | 215.70% | 1.33% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.36 M | $86.20 M | -1.44% | 1.23% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 1.32 M | $83.59 M | -31.08% | 1.19% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.29 M | $81.87 M | 98.02% | 1.17% |
PERPETUAL LTD | 10/09/2024 | 1.27 M | $80.35 M | 55.38% | 1.14% |
BRAIDWELL LP | 11/14/2024 | 1.16 M | $73.25 M | 4.52% | 1.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 1.12 M | $70.60 M | -20.62% | 1.01% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.07 M | $67.46 M | 9.46% | 0.96% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 1.03 M | $65.46 M | -16.70% | 0.93% |
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 10/22/2024 | 1.00 M | $15.86 M | 10,775.57% | 0.91% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 11/12/2024 | 930,370 | $58.90 M | 18.26% | 0.84% |
INVESCO LTD. | 11/12/2024 | 876,222 | $55.47 M | 23.78% | 0.79% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 815,678 | $51.64 M | 14.15% | 0.74% |
CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 738,574 | $46.76 M | 26.34% | 0.67% |
VIKING GLOBAL INVESTORS LP | 11/14/2024 | 721,926 | $45.71 M | -46.70% | 0.65% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 715,597 | $45.30 M | 6.57% | 0.65% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 674,139 | $42.68 M | 8.31% | 0.61% |
PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 593,528 | $37.58 M | 29.93% | 0.54% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 11/14/2024 | 581,418 | $36.81 M | 29.15% | 0.52% |
MACQUARIE GROUP LTD | 11/14/2024 | 568,400 | $35.99 M | -0.05% | 0.51% |
ARTIA GLOBAL PARTNERS LP | 11/14/2024 | 532,879 | $33.74 M | 17.64% | 0.48% |
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 10/21/2024 | 493,950 | $31.27 M | -5.02% | 0.45% |
FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 488,869 | $30.95 M | -13.82% | 0.44% |
JANE STREET GROUP, LLC | 11/15/2024 | 478,800 | $30.31 M | 100.00% | 0.43% |
BAMCO INC /NY/ | 11/14/2024 | 474,644 | $30.05 M | -5.60% | 0.43% |
AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 463,529 | $29.12 M | 580.96% | 0.42% |
D. E. SHAW & CO., INC. | 11/14/2024 | 456,460 | $28.90 M | -13.14% | 0.41% |
EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 452,969 | $28.68 M | 79.06% | 0.41% |
ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 452,011 | $28.62 M | 0.00% | 0.41% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 450,471 | $28.52 M | 59.67% | 0.41% |
RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 441,590 | $27.96 M | 43.17% | 0.40% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 422,833 | $26.77 M | -1.85% | 0.38% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 421,564 | $26.69 M | 3.51% | 0.38% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 406,017 | $25.70 M | 25.40% | 0.37% |
ROYAL BANK OF CANADA | 11/14/2024 | 395,893 | $25.06 M | 48.34% | 0.36% |
EMERALD ADVISERS, LLC | 10/29/2024 | 339,047 | $21.47 M | 3.67% | 0.31% |
JANE STREET GROUP, LLC | 11/15/2024 | 338,807 | $21.45 M | -11.62% | 0.31% |
JANE STREET GROUP, LLC | 11/15/2024 | 338,800 | $21.45 M | 100.00% | 0.31% |
UBS GROUP AG | 11/14/2024 | 328,959 | $20.83 M | -8.47% | 0.30% |
FRANKLIN RESOURCES INC | 11/27/2024 | 328,124 | $21.59 M | -2.97% | 0.30% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 325,287 | $20.59 M | -14.10% | 0.29% |
Viking Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 503 institutional investors and hedge funds held shares of Viking Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 16.62 M
VANGUARD GROUP INC: 10.17 M
BlackRock Funding, Inc. /DE: 5.38 M
STATE STREET CORP: 4.67 M
JPMORGAN CHASE & CO: 2.12 M
MORGAN STANLEY: 1.87 M
74.45% of Viking Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 89.40 M shares in the last 24 months. This purchase volume represents approximately $3.78 B in transactions.